Archives
-
From Reporter Signal to mRNA Translation Strategy
2026-09-14
Firefly Luciferase mRNA can do more than confirm transfection: it can help translational researchers separate delivery performance, cytosolic translation, cellular fitness, and therapeutic mechanism. This thought-leadership guide connects engineered reporter design with lessons from Klotho mRNA delivery in senescent iMSCs.
-
XAV-939: A Mechanism-First Wnt Assay Guide
2026-09-14
XAV-939, also known as NVP-XAV939, is a tankyrase-directed tool for resolving how axin stability reshapes Wnt/β-catenin signaling. This mechanism-first guide connects assay design, cancer research, fibrosis models, osteogenic differentiation, and the ADP-ribosylation findings of a key coronavirus study.
-
Cy5 TSA Fluorescence System Kit for Sensitive Imaging
2026-09-13
The Cy5 TSA Fluorescence System Kit uses horseradish peroxidase catalyzed tyramide deposition to enhance fluorescence in IHC, ICC, and FISH. Its Cy5 readout supports detection of low-abundance targets at 648 nm excitation and 667 nm emission, with product information reporting approximately 100-fold greater sensitivity than conventional assays.
-
Nebivolol Hydrochloride as a Pathway Control
2026-09-12
Nebivolol hydrochloride is more than a selective β1-adrenoceptor antagonist: its negative result in a sensitized yeast TOR assay offers a valuable framework for interpreting pathway specificity. This article connects receptor pharmacology, assay design, and mechanistic controls without treating one model as proof of universal target selectivity.
-
PP 2 (AG 1879) Src Signaling Workflows
2026-09-11
PP 2 (AG 1879) connects potency-aware Src-family kinase inhibition with practical assays for proliferation, invasion, T-cell signaling, and cytoskeletal remodeling. This guide translates the PA–Src–FAK–RhoA/ROCK findings in decidualization into controlled, troubleshootable experiments without overstating what the inhibitor can prove.
-
Liproxstatin-1 HCl: Ferroptosis Assay Guide
2026-09-11
A scenario-driven guide to using Liproxstatin-1 HCl (SKU B8221) in ferroptosis, viability, and cytotoxicity workflows. It connects dose interpretation, solvent handling, selectivity controls, and vendor evaluation to product data and mechanistic literature.
-
DDI2–NFE2L1 Controls Ferroptosis Through the UPS
2026-09-10
The reference study shows that ferroptotic stress remodels the ubiquitin–proteasome system and activates a DDI2-dependent NFE2L1 response that restores proteasome function. Genetic loss or chemical inhibition of DDI2 prevents this adaptive response, increases protein hyperubiquitylation, and sensitizes cells to ferroptotic death.
-
CKI 7 dihydrochloride: Assay Workflow Guide
2026-09-10
This scenario-based guide explains how CKI 7 dihydrochloride, SKU B4936, can support controlled Casein kinase 1 perturbation in viability, proliferation, Wnt, circadian, and apoptosis workflows. It emphasizes solvent control, fresh-solution handling, orthogonal readouts, and cautious interpretation of pathway-specific results.
-
SB-505124 Hydrochloride in Mechanobiology
2026-09-09
SB-505124 hydrochloride is a reversible ALK4/5/7 inhibitor for dissecting TGF-β-driven signaling, fibrosis, and cell mechanics. This article develops a practical bridge between Smad pathway assays and mechanobiology without overstating evidence for direct effects on cancer-cell stiffness.
-
DiscoveryProbe Stem Cell Compound Library Plus Workflow
2026-09-09
DiscoveryProbe™ Stem Cell Compound Library Plus connects broad stem-cell pathway coverage with practical phenotypic, differentiation, and self-renewal workflows. Its application in a quantitative schistosome neoblast screen shows how high-content imaging can reveal functional hits that morphology or motility alone may miss.
-
KNUCKLES and Floral Meristem Termination
2026-09-08
The reference study shows that KNUCKLES coordinates floral meristem termination by repressing PIN1 and IPT7 through H3K27me3-associated regulation, thereby reshaping auxin distribution and cytokinin activity. Its stage-resolved genetic, hormone, transcriptional, and chromatin evidence expands the KNU regulatory model beyond direct control of WUS and CLV3.
-
Anlotinib for Intra-Abdominal Desmoplastic Tumor
2026-09-08
This case report describes radiologic reduction of metastatic intra-abdominal desmoplastic small round cell tumor after anlotinib treatment following surgery and adjuvant chemotherapy. Its main contribution is hypothesis-generating clinical evidence that multi-target receptor tyrosine kinase inhibition may provide a tolerable option for a rare, aggressive sarcoma with limited standardized treatment strategies.
-
XAV-939 Workflows for Wnt and MSC Research
2026-09-07
XAV-939, also called NVP-XAV939, gives researchers a practical way to connect tankyrase inhibition with Wnt/β-catenin pathway readouts, osteogenic differentiation, cancer research, and fibrosis models. This guide combines dose-control strategy with the scalable MSC extracellular-vesicle platform reported in a 2025 reference study, while clearly separating established evidence from proposed assay extensions.
-
iRhom2 in Olfaction: OR Regulation and Adaptation
2026-09-07
The 2024 reference study identifies iRhom2 as an olfactory sensory neuron-associated regulator linked to odorant receptor expression and activity-dependent adaptation. Its combination of mouse genetics, transcriptomics, spatial analysis, and an ectopic receptor-signaling model supports a testable iRhom2/ADAM17 pathway while also defining important limits on causal interpretation.
-
Deep Learning for iPSC-CM Cardiotoxicity Screening
2026-09-05
Grafton and colleagues developed a high-content screening workflow that combines induced pluripotent stem cell-derived cardiomyocytes with deep-learning image analysis to detect cardiotoxic phenotypes. The study shows how a single image-derived score can prioritize toxic liabilities across bioactive compounds and chemically diverse molecules, while also clarifying the limits of phenotype-based interpretation.